BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 8405201)

  • 1. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.
    Pike MC; Spicer DV; Dahmoush L; Press MF
    Epidemiol Rev; 1993; 15(1):17-35. PubMed ID: 8405201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
    King RJ
    Contraception; 1991 Jun; 43(6):527-42. PubMed ID: 1651204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestins and breast cancer: an epidemiologic review.
    Staffa JA; Newschaffer CJ; Jones JK; Miller V
    Fertil Steril; 1992 Mar; 57(3):473-91. PubMed ID: 1740192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer epidemiology: summary and future directions.
    Kelsey JL
    Epidemiol Rev; 1993; 15(1):256-63. PubMed ID: 8405209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of breast cancer.
    Marchant DJ
    Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
    Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
    Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of progesterone and progestins on endometrial proliferation.
    Moyer DL; Felix JC
    Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive factors and breast cancer.
    Kelsey JL; Gammon MD; John EM
    Epidemiol Rev; 1993; 15(1):36-47. PubMed ID: 8405211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraception and cancer prevention.
    Ursin G; Spicer DV; Pike MC
    Adv Contracept Deliv Syst; 1994; 10(3-4):369-86. PubMed ID: 12287845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of oestrogens and progestogens.
    Lauritzen C
    Maturitas; 1990 Sep; 12(3):199-214. PubMed ID: 2215269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on the breast of drugs used in fertility regulation.
    Mauvais-Jarvis P
    Hum Reprod; 1987 Feb; 2(2):159-62. PubMed ID: 3473070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can breast cancer be prevented?].
    Vatten LJ
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1745-8. PubMed ID: 2063386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
    Battersby S; Robertson BJ; Anderson TJ; King RJ; McPherson K
    Br J Cancer; 1992 Apr; 65(4):601-7. PubMed ID: 1562470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.